Wells Fargo & Company Olink Holding Ab (Publ) Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$14.45 - $20.34 $245 - $345	-17 Reduced 14.53%	100 $1,000
Q1 2023 May 12, 2023	BUY	$19.34 - $24.11 $212 - $265	11 Added 10.38%	117 $2,000
Q4 2022 Feb 13, 2023	SELL	$12.64 - $25.52 $300,541 - $606,789	-23,777 Reduced 99.56%	106 $2,000
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $288,604 - $437,898	23,773 Added 21611.82%	23,883 $290,000
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $54 - $104	3 Added 2.8%	110 $2,000
Q3 2021 Nov 15, 2021	SELL	$23.42 - $37.93 $1,077 - $1,744	-46 Reduced 30.07%	107 $2,000
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $3,731 - $5,525	140 Added 1076.92%	153 $5,000
Q1 2021 May 13, 2021	BUY	$31.9 - $36.0 $414 - $468	13 New	13 $0

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.